Literature DB >> 17960249

TNF-alpha induces leukemic clonal evolution ex vivo in Fanconi anemia group C murine stem cells.

June Li1, Daniel P Sejas, Xiaoling Zhang, Yuhui Qiu, Kalpana J Nattamai, Reena Rani, Keaney R Rathbun, Hartmut Geiger, David A Williams, Grover C Bagby, Qishen Pang.   

Abstract

The molecular pathogenesis of the myeloid leukemias that frequently occur in patients with Fanconi anemia (FA) is not well defined. Hematopoietic stem cells bearing inactivating mutations of FA complementation group C (FANCC) are genetically unstable and hypersensitive to apoptotic cytokine cues including IFN-gamma and TNF-alpha, but neoplastic stem cell clones that arise frequently in vivo are resistant to these cytokines. Reasoning that the combination of genetic instability and cytokine hypersensitivity might create an environment supporting the emergence of leukemic stem cells, we tested the leukemia-promoting effects of TNF-alpha in murine stem cells. TNF-alpha exposure initially profoundly inhibited the growth of Fancc-/- stem cells. However, longer-term exposure of these cells promoted the outgrowth of cytogenetically abnormal clones that, upon transplantation into congenic WT mice, led to acute myelogenous leukemia. TNF-alpha induced ROS-dependent genetic instability in Fancc-/- but not in WT cells. The leukemic clones were TNF-alpha resistant but retained their characteristic hypersensitivity to mitomycin C and exhibited high levels of chromosomal instability. Expression of FANCC cDNA in Fancc-/- stem cells protected them from TNF-alpha-induced clonal evolution. We conclude that TNF-alpha exposure creates an environment in which somatically mutated preleukemic stem cell clones are selected and from which unaltered TNF-alpha-hypersensitive Fancc-/- stem cells are purged.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17960249      PMCID: PMC2040318          DOI: 10.1172/JCI31772

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  58 in total

1.  Positional cloning of a novel Fanconi anemia gene, FANCD2.

Authors:  C Timmers; T Taniguchi; J Hejna; C Reifsteck; L Lucas; D Bruun; M Thayer; B Cox; S Olson; A D D'Andrea; R Moses; M Grompe
Journal:  Mol Cell       Date:  2001-02       Impact factor: 17.970

2.  The Fanconi anemia protein FANCF forms a nuclear complex with FANCA, FANCC and FANCG.

Authors:  J P de Winter; L van der Weel; J de Groot; S Stone; Q Waisfisz; F Arwert; R J Scheper; F A Kruyt; M E Hoatlin; H Joenje
Journal:  Hum Mol Genet       Date:  2000-11-01       Impact factor: 6.150

3.  Cloning of cDNAs for Fanconi's anaemia by functional complementation.

Authors:  C A Strathdee; H Gavish; W R Shannon; M Buchwald
Journal:  Nature       Date:  1992-04-30       Impact factor: 49.962

4.  Direct interactions of the five known Fanconi anaemia proteins suggest a common functional pathway.

Authors:  A L Medhurst; P A Huber; Q Waisfisz; J P de Winter ; C G Mathew
Journal:  Hum Mol Genet       Date:  2001-02-15       Impact factor: 6.150

5.  Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway.

Authors:  I Garcia-Higuera; T Taniguchi; S Ganesan; M S Meyn; C Timmers; J Hejna; M Grompe; A D D'Andrea
Journal:  Mol Cell       Date:  2001-02       Impact factor: 17.970

Review 6.  Selective pressure as an essential force in molecular evolution of myeloid leukemic clones: a view from the window of Fanconi anemia.

Authors:  M W Lensch; R K Rathbun; S B Olson; G R Jones; G C Bagby
Journal:  Leukemia       Date:  1999-11       Impact factor: 11.528

7.  FANCC interacts with Hsp70 to protect hematopoietic cells from IFN-gamma/TNF-alpha-mediated cytotoxicity.

Authors:  Q Pang; W Keeble; T A Christianson; G R Faulkner; G C Bagby
Journal:  EMBO J       Date:  2001-08-15       Impact factor: 11.598

8.  The Fanconi anemia protein FANCC binds to and facilitates the activation of STAT1 by gamma interferon and hematopoietic growth factors.

Authors:  Q Pang; S Fagerlie; T A Christianson; W Keeble; G Faulkner; J Diaz; R K Rathbun; G C Bagby
Journal:  Mol Cell Biol       Date:  2000-07       Impact factor: 4.272

9.  Isolation of a cDNA representing the Fanconi anemia complementation group E gene.

Authors:  J P de Winter; F Léveillé; C G van Berkel; M A Rooimans; L van Der Weel; J Steltenpool; I Demuth; N V Morgan; N Alon; L Bosnoyan-Collins; J Lightfoot; P A Leegwater; Q Waisfisz; K Komatsu; F Arwert; J C Pronk; C G Mathew; M Digweed; M Buchwald; H Joenje
Journal:  Am J Hum Genet       Date:  2000-09-19       Impact factor: 11.025

10.  Functional correction of FA-C cells with FANCC suppresses the expression of interferon gamma-inducible genes.

Authors:  S R Fagerlie; J Diaz; T A Christianson; K McCartan; W Keeble; G R Faulkner; G C Bagby
Journal:  Blood       Date:  2001-05-15       Impact factor: 22.113

View more
  74 in total

1.  Impaired function of Fanconi anemia type C-deficient macrophages.

Authors:  Ying Liu; Kimberly Ballman; Deqiang Li; Shehnaz Khan; Ethel Derr-Yellin; Weinian Shou; Laura S Haneline
Journal:  J Leukoc Biol       Date:  2011-11-21       Impact factor: 4.962

2.  Bone marrow failure in Fanconi anemia is triggered by an exacerbated p53/p21 DNA damage response that impairs hematopoietic stem and progenitor cells.

Authors:  Raphael Ceccaldi; Kalindi Parmar; Enguerran Mouly; Marc Delord; Jung Min Kim; Marie Regairaz; Marika Pla; Nadia Vasquez; Qing-Shuo Zhang; Corinne Pondarre; Régis Peffault de Latour; Eliane Gluckman; Marina Cavazzana-Calvo; Thierry Leblanc; Jérôme Larghero; Markus Grompe; Gérard Socié; Alan D D'Andrea; Jean Soulier
Journal:  Cell Stem Cell       Date:  2012-06-07       Impact factor: 24.633

3.  Spontaneous abrogation of the G₂DNA damage checkpoint has clinical benefits but promotes leukemogenesis in Fanconi anemia patients.

Authors:  Raphael Ceccaldi; Delphine Briot; Jérôme Larghero; Nadia Vasquez; Catherine Dubois d'Enghien; Delphine Chamousset; Maria-Elena Noguera; Quinten Waisfisz; Olivier Hermine; Corinne Pondarre; Thierry Leblanc; Eliane Gluckman; Hans Joenje; Dominique Stoppa-Lyonnet; Gérard Socié; Jean Soulier
Journal:  J Clin Invest       Date:  2010-12-22       Impact factor: 14.808

4.  Discovering early molecular determinants of leukemogenesis.

Authors:  Grover C Bagby
Journal:  J Clin Invest       Date:  2008-03       Impact factor: 14.808

Review 5.  Mouse models of Fanconi anemia.

Authors:  Kalindi Parmar; Alan D'Andrea; Laura J Niedernhofer
Journal:  Mutat Res       Date:  2009-04-10       Impact factor: 2.433

Review 6.  Diamond-Blackfan anemia: diagnosis, treatment, and molecular pathogenesis.

Authors:  Jeffrey M Lipton; Steven R Ellis
Journal:  Hematol Oncol Clin North Am       Date:  2009-04       Impact factor: 3.722

Review 7.  Oxidative stress-associated protein tyrosine kinases and phosphatases in Fanconi anemia.

Authors:  Jie Li; Qishen Pang
Journal:  Antioxid Redox Signal       Date:  2014-03-11       Impact factor: 8.401

Review 8.  TNF-α, a good or bad factor in hematological diseases?

Authors:  Tian Tian; Min Wang; Daoxin Ma
Journal:  Stem Cell Investig       Date:  2014-06-01

9.  Metformin improves defective hematopoiesis and delays tumor formation in Fanconi anemia mice.

Authors:  Qing-Shuo Zhang; Weiliang Tang; Matthew Deater; Ngoc Phan; Andrea N Marcogliese; Hui Li; Muhsen Al-Dhalimy; Angela Major; Susan Olson; Raymond J Monnat; Markus Grompe
Journal:  Blood       Date:  2016-10-18       Impact factor: 22.113

10.  Combinatorial Efficacy of Quercitin and Nanoliposomal Ceramide for Acute Myeloid Leukemia.

Authors:  Colin M McGill; Timothy J Brown; Lindsey N Fisher; Sally J Gustafson; Kriya L Dunlap; Adam J Beck; Paul T Toran; David F Claxton; Brian M Barth
Journal:  Int J Biopharm Sci       Date:  2018-01-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.